Moderate to Severe Plaque OR Scalp Psoriasis Trial (116 Weeks)

  • Adults at least 18 years of age who self-identify as non-white, may qualify to participate.
  • Must have a diagnosis of plaque psoriasis (with or without psoriatic arthritis) for at least 6 months before first administration of study drug OR expert panel confirmed psoriasis diagnosis (based on
    clinical photos) OR biopsy confirmed psoriasis.
  • Individuals must also have moderate to severe plaque psoriasis, with involvement of 10% or more body surface area (BSA) OR have moderate to severe scalp psoriasis, with involvement of 30% or more scalp surface area and at least one
    plaque outside of the scalp.
  • Participants will receive investigational treatment (active study drug) or placebo, via injection.
  • Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
  • Study participation will last about 116 weeks and involve about 20 visits to the study centre.

If interested, please contact our Research Coordinator  at 416-633-0001 x 4 or e-mail [email protected].

    Shopping Bag
    Your cart is emptyReturn to Shop
      Calculate Shipping
      Apply Coupon